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▼Hereditary hemochromatosis (HH) is an autosomal reces-
sive disease in which iron absorption by the small bowel is
not regulated appropriately and excessive iron stores accu-
mulate. Direct toxicity from the stored iron becomes severe
when body iron loads reach values of the order of tenfold
or greater than normal, causing cirrhosis, endocrine fail-
ure, joint inflammation and heart failure. It has recently
been reported that 87% of HH patients contain a mis-
sense Cys282Tyr mutation in the HLA-H gene on chro-
mosome 6 (Ref. 1). Subsequently, other groups have con-
firmed the finding and demonstrated the mutation in 90%
and 100% of HH patients examined, respectively (Ref. 2, 3).
The implication of another variant, His63Asp, in the HLA-
H was less clear and might represent only a polymorphism
(Ref. 1, 2, 3). Thus the Cys282Tyr mutation appears to
be more highly associated with HH than His63Asp. The
early detection of HH in its lengthy pre-symptomatic phase
would be beneficial because the surrounding complications
are preventable by repeated phlebotomy. Here we report a
rapid identification of the Cys282Tyr mutation by allele-
specific PCR (AS-PCR).
Protocol
Four different oligonucleotide primers were prepared. This
assay is made possible by carrying out PCR under stringent
conditions where the primers F1 (AAGCAGCCAATGGAT-
GCCAAG) and Rm (CCTGGGTGCTCCACCTGGT) gener-
ate PCR products from only the mutant allele and not
from the normal allele because of a mismatch at the 3’
end of the primer Rm (Fig. 1a, b). Likewise, the primers
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Fw (GGGAAGAGCAGAGATATACGTG) and R1 (CCACT-
GATGACTCCAATGACTA) generate PCR products derived
from only the normal allele and not from the mutant al-
lele because of a mismatch at the 3’ end of the primer Fw.
PCR reaction mixtures consist of 50 ng genomic DNA as
template, 0.2 mM of each dNTPs, 250 nM Rm, 750 nM Fw,
500 nM F1, 500 nM R1 and 0.5 U Amplitaq Gold
(Perkin-Elmer) for the hot-start PCR in 20 µl total volume.
Conditions for amplification were an initial denaturation
at 95◦C for 11 min followed by 28 cycles of denaturation at
95◦C for 30 s, annealing at 65◦C for 30 s and extension at
72◦C for 30 s, with a final extension at 72◦C for 10 min.
The AS-PCR products from a normal subject show the nor-
mal allele and the common product whereas PCR products
from an HH patient show the mutant allele and the com-
mon product, and those from a carrier show the normal
allele, the mutant allele and the common product (Fig. 1c).
It has been reported that the Cys282Tyr mutation creates a
new SnaBI or RsaI restriction site (Ref. 2, 3). For confirma-
tion, we took the opportunity to compare the result of the
AS-PCR with that of RsaI digest of PCR products amplified
by using the same genomic DNA as template, and primers
F1 and R1. A normal subject shows the normal allele only,
whereas an HH patient shows the mutant allele only, and a
carrier shows both the normal and mutant alleles (Fig. 1d).
The data indicate that AS-PCR is an obvious ad-
vance over the conventional method using RsaI digestion
of PCR products the results of which may occasion-
ally be difficult to interpret because of the partial
digestion of PCR products or the presence of het-
eroduplexes in the PCR products. Furthermore, the
AS-PCR is a fast, economical, efficient and simple
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FIGURE 1. (a) Allele specific-PCR (AS-PCR) primer schematics. Each allele is distinguished by its product size. A common product is amplified from
both alleles by the primers F1 and R1. The G to A transition at nucleotide 845 causes the Cys282Tyr mutation and creates the RsaI recognition site (R).
(b) DNA sequence spanning the Cys282Tyr mutation. The primer Fw recognizes only the normal allele sequence while the primer Rm recognizes only
the mutated sequence. Nucleotides are numbered from the first codon of the open reading frame. (c) The AS-PCR amplifies the common and the normal
allele in the normal subject, and the common and the mutant allele in the HH patient. The carrier shows all three products, indicating heterozygosity for
the normal and mutant alleles. (d) The results of AS-PCR were confirmed by RsaI digestion of PCR products generated by F1 and R1 primers. The same
samples were used in both (c) and (d). M, size marker (AluI digested pUC19).
method for the detection of the Cys282Tyr mutation, and
the principle could be applied to any other defined poly-
morphism or point mutation such as single base transition
or transversion.
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Products Used
AmpliTaq DNA polymerase: AmpliTaq DNA
polymerase from PE Applied Biosystems
Taq polymerase: Taq polymerase from Boehringer
Mannheim
AmpliTaq: AmpliTaq from PE Applied Biosystems
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